Here’s one new board member not in awe of the chairman.
Just in case you missed it, a Hong Kong venture capital firm called Deep Knowledge Ventures has just become the first ever to name a robot to its board of directors.
The VC firm focuses on age-related disease drugs and regenerative medicine projects. It has appointed VITAL, a machine learning program capable of making investment recommendations in the life science sector, to its Board.
Not only that, but it gets an equal vote on investment decisions.
The software can intuitively predict the success of a project or a company at the initial seeding level based on analysis of historical data, including the involvement of companies in the supply chain.
VITAL’s software was developed by UK-based Aging Analytics which plans to licence the software to other players in the life science sector.